Skip to main content

Software Effective Solutions "MEDCANA" (OTC: SFWJ) will begin first round of full-scale production of non-THC cannabis in Colombia with one of its subsidiaries

--News Direct--

Software Effective Solutions, (OTC: SFWJ) (“The Company”, “SFWJ”) doing business as MedCana, is pleased to announce that one of its subsidiaries in Colombia will begin full-scale production of non-THC cannabis for export to Europe in response to high demand in the area. This expansion comes after the successful completion of full crop cycle testing and infrastructure development.

The company’s decision to enter the European market is driven by the region’s increasing demand for high-quality, non-THC cannabis products. The production will be in accordance with European Union regulations and the company will be working with its experienced team of agricultural engineers and chemists in Colombia to ensure that the products meet the highest standards.

“We are excited to announce our first run at full scale production with one of our companies, which is a key part of our growth strategy,” said J. Gabriel Diaz CEO of Medcana “Our team has worked diligently to develop a cultivation and production process that ensures the highest quality of non-THC cannabis. We see this as a great first step in execution, which is the most important objective in our company now.”

The subsidiary will begin full-scale production in the next 60 days and is expected to start exporting to Europe in the coming months.

ABOUT SFWJ: Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. Currently, MedCana has five companies focused on pharmaceutical cannabis production, one software company focused on managing processes for plant-to-patient operations. The recent acquisition an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of companies. MedCana's initial focus is on developing clients and companies in Latin America with an initial focus in Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world.


This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.


Jose Gabriel Diaz, CEO

Contact Details


Company Website

View source version on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.